IN VITRO GROWTH INHIBITORY EFFECT OF ZnO NANOPARTICLES ON HUMAN LIVER CANCER CELL LINES (Huh7)

Authors

  • ANANTHALAKSHMI R Department of Biochemistry, Sacred Heart College, Tirupattur, Vellore, Tamil Nadu, India.
  • XAVIER RAJARATHINAM SR Department of Chemistry, Sacred Heart College, Tirupattur, Vellore, Tamil Nadu, India.
  • Mohamed Sadiq A Adhi parasakthi college of arts and science, Kalavai, Vellore Dt
  • MOHAMED SADIQ A Department of Biochemistry, Adhiparasakthi College of Arts and Science, Vellore, Tamil Nadu, India.

DOI:

https://doi.org/10.22159/ajpcr.2019.v12i6.33486

Keywords:

Nanoparticles,, Eco-friendly synthesis,, Electron microscopy,, Anticancer activity,, Huh7 cell lines,, Cellular staining

Abstract

Objective: The objective of the study was to access the anticancer activity of the biosynthesized ZnO nanoparticles against Huh7 liver cancer cell lines.

Methods: The study was carried in vitro using Huh7 cell lines. The ZnO nanoparticles (ZnO NPs) were synthesized using Luffa acutangula peel extract and subjected to characterization by X-ray powder diffraction and transmission electron microscopy. The Huh7 cell lines were treated with ZnO NPs and done 3-(4, 5-dimethylthiazol- 2-yl)-2, 5-diphenyltetrazolium bromide assay. For live and dead assay, the cell lines treated with ZnO NPs were subjected to acridine orange/ethidium (AO/ET) bromide assay.

Results: The ZnO NPs synthesized show spherical structure with 10–20 nm size. The 50% of Huh7 proliferation were inhibited at the concentration (IC50) of 40 μg/ml. The AO/ET assay shows compact nucleus and fine cytoplasmic morphology in control cells and apoptotic stage in treated cells

Conclusion: This study suggests that ZnO NPs can be prepared in environment-friendly method using aqueous extract of L. acutangula and can be used in cancer treatment effectively.

Downloads

Download data is not yet available.

References

Murugesan S, Bhuvaneswari S, Sivamurugan V. Green synthesis, characterization of silver nanoparticles of a marine red alga Spyridia fusiformis and their antibacterial activity. Int J Pharm Pharm Sci 2017; 9:192-7.

Bhosale RR, Kulkarni AS, Gilda SS, Aloorkar NH, Osmani RA, Harkare BR. Innovative eco-friendly approaches for green synthesis of silver nanoparticles. Int J Pharm Sci Nanotechnol 2014;7:2328-37.

Salam H, Rajiv P, Kamaraj M. Plants: Green route for nanoparticle synthesis. Int Res J Biol Sci 2012;1:85-90.

An J, Wang D, Luo Q, Yuan X. Antimicrobial active silver nanoparticles and silver/polystyrene core-shell nanoparticles prepared in room-temperature ionic liquid. Mater Sci Eng C Mater Biol Appl 2009;29:1984-9.

Ruszkiewicz JA, Pinkas A, Ferrer B, Peres TV, Tsatsakis A, Aschner M, et al. Neurotoxic effect of active ingredients in sunscreen products, a contemporary review. Toxicol Rep 2017;4:245-59.

Sankar R, Dhivya R, Shivashangari KS, Ravikumar V. Wound healing activity of Origanum vulgare engineered titanium dioxide nanoparticles in Wistar albino rats. J Mater Sci Mater Med 2014;25:1701-8.

Sharmila G, Thirumarimurugan M, Sivakumar VM. Optical, catalytic and antibacterial properties of phytofabricated CuO nanoparticles using Tecoma castanifolia leaf extract. Optik 2016;127:7822-8.

Unno Y, Shino Y, Kondo F, Igarashi N, Wang G, Shimura R, et al. Oncolytic viral therapy for cervical and ovarian cancer cells by Sindbis virus AR339 strain. Clin Cancer Res 2005;11:4553-60.

Abraham SA, McKenzie C, Masin D, Ng R, Harasym TO, Mayer LD, et al. In vitro and in vivo characterization of doxorubicin and vincristine coencapsulated within liposomes through use of transition metal ion complexation and pH gradient loading. Clin Cancer Res 2004; 10:728 38.

Boroumand Moghaddam A, Moniri M, Azizi S, Abdul Rahim R, Bin Ariff A, Navaderi M, et al. Eco-friendly formulated zinc oxide nanoparticles: Induction of cell cycle arrest and apoptosis in the MCF-7 cancer cell line. Genes (Basel) 2017;8:281.

Rehana D, Mahendiran D, Kumar RS, Rahiman AK. Evaluation of antioxidant and anticancer activity of copper oxide nanoparticles synthesized using medicinally important plant extracts. Biomed Pharmacother 2017;89:1067-77.

Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 1982;42:3858-63.

Chaudhary S, Chandrashekar KS, Pai KS, Setty MM, Devkar RA, Reddy ND, et al. Evaluation of antioxidant and anticancer activity of extract and fractions of Nardostachys jatamansi DC in breast carcinoma. BMC Complement Altern Med 2015;15:50.

Kasibhatla S, Amarante-Mendes GP, Finucane D, Brunner T, Bossy- Wetzel E, Green DR, et al. Acridine orange/ethidium bromide (AO/EB) staining to detect apoptosis. CSH Protoc 2006;2006:4493.

Selvakumari D, Deepa R, Mahalakshmi V, Subhashini P, Lakshminarayan N. Anti cancer activity of ZnO nanoparticles on MCF7(Breast cancer cell) and A549 (Lung cancer cell). ARPN J Eng Appl Sci 2015;10:5418-21.

Ratney YJ, David SB. Evaluation of in vitro anticancer and antioxidant activity of zinc oxide nanoparticle by chemical and green method. Int J Latest Trends Eng Technol 2017;8:10-5.

Moghaddam AB, Moniri M, Azizi S, Rahim RA, Ariff AB, Navaderi M, et al. Eco-friendly formulated Zinc Oxide nanoparticles: Induction of cell cycle arrest and apoptosis in the MCF-7 cancer cell line. Genes (Basel) 2017;8:1-15.

Lingaraju K, Naika HR, Nagabhushana H, Nagaraju G. Euphorbia heterophylla (L.) mediated fabrication of ZnO NPs: Characterization and evaluation of antibacterial and anticancer properties. Biocatal Agric Biotechnol 2018;18:1-27.

Al Rashid MH, Bharadwaj PV, Mandal VM, Pal M, Mandal SC, Thandavarayan RA. Antioxidant and anticancer activity of extract and fractions obtained from Diospyros melanoxylon Roxb. Leaves and correlation with their polyphenolic profiles. Int J Pharm Pharm Sci 2018;10:6-16.

Published

07-06-2019

How to Cite

ANANTHALAKSHMI R, XAVIER RAJARATHINAM SR, Mohamed Sadiq A, and MOHAMED SADIQ A. “IN VITRO GROWTH INHIBITORY EFFECT OF ZnO NANOPARTICLES ON HUMAN LIVER CANCER CELL LINES (Huh7)”. Asian Journal of Pharmaceutical and Clinical Research, vol. 12, no. 6, June 2019, pp. 191-3, doi:10.22159/ajpcr.2019.v12i6.33486.

Issue

Section

Original Article(s)